Drugmakers would have until 2032 to cut ties with WuXi AppTec and other Chinese life sciences companies, according to an ...
Bernie Sanders (I-VT) and Jeff Merkley (D-OR) accused a new US Chamber of Commerce coalition of attempting to “stymie the ...
Several secretive and well-funded biotechs are sharing the first glimpses of data from a new suite of gene editing tools that ...
Maze Therapeutics has found a new buyer for its Pompe disease candidate, five months after scrutiny from the Federal Trade ...
Bluebird bio’s stock $BLUE jumped over 20% on Thursday following its first-quarter earnings release and the announcement of ...
Ginkgo Bioworks is looking to cut expenses and personnel in an effort to return to profitability and break even by ...
Lawmakers in the House Energy and Commerce Committee criticized the management of the national stockpile in a ...
Verona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine. Under new ...
As the head of the trade group BIO and a parent to children with a rare disease, John Crowley is personally and ...
California biotech Attovia Therapeutics is back with a $105 million Series B just 11 months after unveiling with $60 million.
A small San Diego biotech wants to take a different approach to the weight loss drug R&D field by going after hunger rather ...
MacroGenics reported on Thursday afternoon that three patients died in a mid-stage trial of its antibody-drug ...